Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum

Abstract Background Alzheimer’s disease (AD) cerebrospinal fluid (CSF) core biomarkers (Aβ42/40 ratio, p-tau, and t-tau) provide high diagnostic accuracy, even at the earliest stage of disease. However, these markers do not fully reflect the complex AD pathophysiology. Recent large scale CSF proteom...

Descripció completa

Dades bibliogràfiques

Autors principals:	Silvia Paciotti, Anna Lidia Wojdała, Giovanni Bellomo, Andrea Toja, Elena Chipi, Sander R. Piersma, Thang V. Pham, Lorenzo Gaetani, Connie R. Jimenez, Lucilla Parnetti, Davide Chiasserini
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2023-07-01
Col·lecció:	Alzheimer’s Research & Therapy
Matèries:	Alzheimer’s disease Cerebrospinal fluid Biomarkers Preclinical AD Pyruvate kinase Aldolase
Accés en línia:	https://doi.org/10.1186/s13195-023-01269-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!